Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation.
Journal
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
19
02
2020
accepted:
07
04
2020
revised:
07
04
2020
pubmed:
15
5
2020
medline:
3
8
2021
entrez:
15
5
2020
Statut:
ppublish
Résumé
Ovarian germ cell tumors, including yolk sac tumors, are most commonly diagnosed in children and young women. Most so-called yolk sac tumors reported in women >35 years old have been associated with an epithelial proliferation (endometriosis or carcinoma). Here, we describe eight cases clinically diagnosed as uterine or ovarian germ cell tumors in women >35 years old. In addition to routine morphologic examination and immunohistochemical evaluation, we present data from targeted next-generation sequencing (NGS) and isochromosome (12p) fluorescence in situ hybridization (FISH). We identified two groups of tumors with mixed germ cell and epithelial features: (1) tumors with background endometriosis and endometrioid carcinoma-like mutations (PTEN, PIK3CA, FGFR2, and CTNNB1), and (2) high-grade morphology, presumptive presence of isochromosome (12p) by FISH, and TP53 or PIK3CA mutations. These findings support the notion that the "germ cell tumor" component of these tumors is often somatically derived. Two tumors in our cohort were from premenopausal women; one showed no detectable mutations by NGS (suggestive of germ cell derivation), whereas the other showed PIK3CA, PTEN, and CTNNB1 mutations (suggestive of somatic derivation). Accurate classification of these tumors is likely important for selection of appropriate chemotherapy.
Identifiants
pubmed: 32404953
doi: 10.1038/s41379-020-0548-6
pii: S0893-3952(22)00468-9
doi:
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1989-2000Références
Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF. Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000;95:128–33.
pubmed: 10636515
Guillem V, Poveda A. Germ cell tumours of the ovary. Clin Transl Oncol. 2007;9:237–43.
pubmed: 17462976
doi: 10.1007/s12094-007-0045-0
Roma AA, Przybycin CG. Yolk sac tumor in postmenopausal patients: pure or associated with adenocarcinoma, a rare phenomenon. Int J Gynecol Pathol. 2014;33:477–82.
pubmed: 25083963
doi: 10.1097/PGP.0000000000000078
McNamee T, Damato S, McCluggage WG. Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumors. Histopathol. 2016;69:739–51.
doi: 10.1111/his.13021
Brown JR, Green JD. Yolk sac carcinoma. South Med J. 1976;69:728–31.
pubmed: 945615
doi: 10.1097/00007611-197606000-00017
Lange S, Livasy C, Tait DL. Endodermal sinus tumor of the ovary in an 86 year old woman. Gynecologic Oncol Rep. 2012;2:65–66.
Oh C, Kendler A, Hernandez E. Ovarian endodermal sinus tumor in a postmenopausal woman. Gynecol Oncol. 2001;82:392–4.
pubmed: 11531302
doi: 10.1006/gyno.2001.6286
Kinoshita K. A 62-year-old woman with endodermal sinus tumor of the ovary. Am J Obstet Gynecol. 1990;162:760–2.
pubmed: 2316585
doi: 10.1016/0002-9378(90)91003-U
Roth LM, Talerman A, Levy T, Sukmanov O, Czernobilsky B. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component. Int J Gynecol Pathol. 2011;30:442–51.
pubmed: 21804392
doi: 10.1097/PGP.0b013e3182164386
Nogales FF, Bergeron C, Carvia RE, Alvaro T, Fulwood HR. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm: analysis of six cases. Am J Surg Pathol. 1996;20:1056–66.
pubmed: 8764742
doi: 10.1097/00000478-199609000-00003
Rutgers JL, Young RH, Scully RE. Ovarian yolk sac tumor arising from an endometrioid carcinoma. Hum Pathol. 1987;18:1296–9.
pubmed: 3679203
doi: 10.1016/S0046-8177(87)80418-5
Horiuchi A, Osada R, Nakayama K, Toki T, Nikaido T, Fujii S. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53. Gynecol Oncol. 1998;70:295–9.
pubmed: 9740709
doi: 10.1006/gyno.1998.5048
Abe A, Furumoto H, Yoshida K, Nishimura M, Irahara M, Kudo E, et al. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component. Int J Gynecol Cancer. 2008;18:168–72.
pubmed: 17466041
doi: 10.1111/j.1525-1438.2007.00952.x
Lopez JM, Malpica A, Deavers MT, Ayala AG. Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary. Ann Diagn Pathol. 2003;7:300–5.
pubmed: 14571433
doi: 10.1016/S1092-9134(03)00081-9
McBee WC, Brainard J Jr, Sawady J, Rose PG. Yolk sac tumor of the ovary associated with endometrioid carcinoma with metastasis to the vagina: a case report. Gynecol Oncol. 2007;105:244–7.
pubmed: 17316775
doi: 10.1016/j.ygyno.2006.07.042
Kamoi S, Ohaki Y, Mori O, Okada S, Seto M, Matsushita N, et al. A case of ovarian endometrioid adenocarcinoma with yolk sac tumor component in a postmenopausal woman. APMIS. 2002;110:508–14.
pubmed: 12193212
doi: 10.1034/j.1600-0463.2002.100609.x
Varia M, McCluggage WG, Oommen R. High grade serous carcinoma of the ovary with a yolk sac tumour component in a postmenopausal woman: report of an extremely rare phenomenon. J Clin Pathol. 2012;65:853–4.
pubmed: 22496516
doi: 10.1136/jclinpath-2011-200606
McCarthy WA, Masand RP. Ovarian yolk sac tumor with high-grade serous carcinoma in a 62-year-old woman. Int J Surg Pathol. 2016;24:360–5.
pubmed: 26782153
doi: 10.1177/1066896915626796
Chen Q, Chen X. Bilateral ovarian mixed epithelial adenocarcinoma in a postmenopausal woman with unilateral ovarian yolk sac tumor component. Int J Clin Exp Pathol. 2014;7:8259–65.
pubmed: 25550883
pmcid: 4270633
Mazur MT, Talbot WH Jr, Talerman A. Endodermal sinus tumor and mucinous cystadenofibroma of the ovary: occurrence in an 82-year-old woman. Cancer. 1988;62:2011–5.
pubmed: 2458826
doi: 10.1002/1097-0142(19881101)62:9<2011::AID-CNCR2820620923>3.0.CO;2-Y
Arai T, Kitayama Y, Koda K. Ovarian mucinous cystadenocarcinoma with yolk sac tumor in a 71-year-old woman. Int J Gynecol Pathol. 1999;18:277–80.
pubmed: 12090598
doi: 10.1097/00004347-199907000-00015
Takizawa K, Kawana T, Kakinoki S, Saito R, Takeda Y. Case report of a 69-year-old woman with double cancers: primary yolk sac tumor of the right ovary and primary serous surface papillary carcinoma of the peritoneum. Int J Clin Oncol. 1996;1:190–4.
doi: 10.1007/BF02348388
Hu YJ, Ip PC, Chan KL, Tam KF, Ngan HY. Ovarian clear cell carcinoma with choriocarcinomatous differentiation: report of a rare and aggressive tumor. Int J Gynecol Pathol. 2010;29:539–45.
pubmed: 20881859
doi: 10.1097/PGP.0b013e3181e7cc66
Shanmugasundarama G, Sundaramoorthya E, Sudalaiandib S, Kondaveeti SS, Johnson T, Swaminathan R, et al. Double pathology: malignant epithelial ovarian tumor and germ cell tumor (choriocarcinoma), a rare coexistence. World J Oncol. 2015;6:421–5.
doi: 10.14740/wjon848w
Hafezi-Bakhtiari S, Morava-Protzner I, Burnell MJ, Reardon E, Colgan TJ. Choriocarcinoma arising in a serous carcinoma of ovary: an example of histopathology driving treatment. J Obstet Gynaecol Can. 2010;32:698–702.
pubmed: 20707961
doi: 10.1016/S1701-2163(16)34574-1
Mukonoweshuro P, McCluggage WG. Clear cell carcinoma of the cervix with choriocarcinomatous differentiation: report of an extremely rare phenomenon associated with mismatch repair protein abnormality. Int J Gynecol Pathol. 2017;36:323–7.
pubmed: 28118159
doi: 10.1097/PGP.0000000000000328
Xing D, Zheng G, Pallavajjala A, Schoolmeester JK, Liu Y, Haley L, et al. Lineage-specific alterations in gynecologic neoplasms with choriocarcinomatous differentiation: implications for origin and therapeutics. Clin Cancer Res. 2019;25:4516–29.
pubmed: 31010836
doi: 10.1158/1078-0432.CCR-18-4278
Horn LC, Hänel C, Bartholdt E, Dietel J. Serous carcinoma of the endometrium with choriocarcinomatous differentiation: a case report and review of the literature indicate the existence of 2 prognostically relevant tumor types. Int J Gynecol Pathol. 2006;25:247–51.
pubmed: 16810062
doi: 10.1097/01.pgp.0000215294.45738.a4
Clement PB, Young RH. Endometrioid-like variant of ovarian yolk sac tumor: a clinicopathological analysis of eight cases. Am J Surg Pathol. 1987;11:767–78.
pubmed: 3661822
doi: 10.1097/00000478-198710000-00004
Atkin NB, Baker MC. Specific chromosome change, i(12p), in testicular tumours? Lancet. 1982;2:1349.
pubmed: 6128640
doi: 10.1016/S0140-6736(82)91557-4
Rosenberg C, Van Gurp RJ, Geelen E, Oosterhuis JW, Looijenga LH. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene. 2000;19:5858–62.
pubmed: 11127816
doi: 10.1038/sj.onc.1203950
Van Nieuwenhuysen E, Busschaert P, Neven P, Han SN, Moerman P, Liontos M, et al. The genetic landscape of 87 ovarian germ cell tumors. Gynecol Oncol. 2018;151:61–8.
pubmed: 30170975
doi: 10.1016/j.ygyno.2018.08.013
Jenkyn DJ, McCartney AJ. A chromosome study of three ovarian tumors. Cancer Genet Cytogenet. 1987;26:327–37.
pubmed: 3471312
doi: 10.1016/0165-4608(87)90067-7
Atkin NB, Baker MC. Abnormal chromosomes including small metacentrics in 14 ovarian cancers. Cancer Genet Cytogenet. 1987;26:355–61.
pubmed: 3032405
doi: 10.1016/0165-4608(87)90070-7
Dal Cin P, Marynen P, Moerman P, Vergot I, Van, den Berghe H. Ovarian germ cell tumor with chromosome 12 anomaly but without i(12p). Cancer Genet Cytogenet. 1996;91:61–4.
pubmed: 8908168
doi: 10.1016/S0165-4608(96)00126-4
Rodriguez E, Melamed J, Reuter V, Chaganti RS. Chromosome 12 abnormalities in malignant ovarian germ cell tumors. Cancer Genet Cytogenet. 1995;82:62–6.
pubmed: 7627937
doi: 10.1016/0165-4608(95)00067-Y
Riopel MA, Spellerberg A, Griffin CA, Perlman EJ. Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization. Cancer Res. 1998;58:3105–10.
pubmed: 9679978
Kraggerud SM, Szymanska J, Abeler VM, Kaern J, Eknaes M, Heim S, et al. DNA copy number changes in malignant ovarian germ cell tumors. Cancer Res. 2000;60:3025–30.
pubmed: 10850452
Cossu-Rocca P, Zhang S, Roth LM, Eble JN, Zheng W, Karim FW, et al. Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis. Mod Pathol. 2006;19:611–5.
pubmed: 16554737
doi: 10.1038/modpathol.3800576
Kraggerud SM, et al. Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis. Endocr Rev. 2013;34:339–76.
pubmed: 23575763
pmcid: 3787935
doi: 10.1210/er.2012-1045
Mayo Foundation for Medical Education and Research. Germ cell tumor (GCT), isochromosome 12p, FISH, Tissue [Mayo Clinic Laboratories Test Catalog Web site]. 2019. https://mayocliniclabs.com/test-catalog/Performance/35270 . Accessed 10 Oct 2019.
The Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67–73.
doi: 10.1038/nature12113
Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23:703–13.
pubmed: 28481359
pmcid: 5461196
doi: 10.1038/nm.4333
Byron SA, Gartside M, Powell MA, Wellens CL, Gao F, Mutch DG, et al. FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features. PLoS One. 2012;7:e30801.
pubmed: 22383975
pmcid: 3285611
doi: 10.1371/journal.pone.0030801
Dutt A, Salvesen HB, Chen TH, Ramos AH, Onofrio RC, Hatton C, et al. Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proc Natl Acad Sci U S A. 2008;105:8713–7.
pubmed: 18552176
pmcid: 2438391
doi: 10.1073/pnas.0803379105
Sookram J, Levin B, Barroeta J, Kenley K, Mehta P, Krill LS. A case of ovarian endometrioid adenocarcinoma with yolk sac differentiation and Lynch syndrome. Gynecologic Oncol Rep. 2019;27:60–4.
doi: 10.1016/j.gore.2019.01.001
Cao D, Guo S, Allan RW, Molberg KH, Peng Y. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009;33:894–904.
pubmed: 19295406
doi: 10.1097/PAS.0b013e318198177d
Miettinen M, Wang Z, McCue PA, Sarlomo-Rikala M, Rys J, Biernat W, et al. SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases. Am J Surg Pathol. 2014;38:410–20.
pubmed: 24525512
pmcid: 4041084
doi: 10.1097/PAS.0000000000000116
Fadare O, Shaker N, Alghamdi A, Ganesan R, Hanley KZ, Hoang LN, et al. Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal. Mod Pathol. 2019;32:1847–60.
pubmed: 31375771
doi: 10.1038/s41379-019-0341-6
Forte A, Schettino MT, Finicelli M, Cipollaro M, Colacurci N, Cobellis L, et al. Expression pattern of stemness-related genes in human endometrial and endometriotic tissues. Mol Med. 2009;15:392–401.
pubmed: 19690622
pmcid: 2727462
doi: 10.2119/molmed.2009.00068
Casper S, van Nagell JR Jr, Powell DF, Dubilier LD, Donaldson ES, Hanson MB, et al. Immunohistochemical localization of tumor markers in epithelial ovarian cancer. Am J Obstet Gynecol. 1984;149:154–8.
pubmed: 6202143
doi: 10.1016/0002-9378(84)90188-1
Hakim SA, Raboh NM. Immunohistochemical expression of glypican 3 in endometrial carcinoma and correlation with prognostic parameters. Int J Clin Exp Pathol. 2015;8:13225–32.
pubmed: 26722522
pmcid: 4680467
Garcia RL, Ghali VS. Gastric choriocarcinoma and yolk sac tumor in a man: observations about its possible origin. Hum Pathol. 1985;16:955–8.
pubmed: 4040885
doi: 10.1016/S0046-8177(85)80137-4
Morinaga S, Nishiya H, Inafuku T. Yolk sac tumor of the liver combined with hepatocellular carcinoma. Arch Pathol Lab Med. 1996;120:687–90.
pubmed: 8757478
Ramakumar S, Cheville JC, Zincke H. Urothelial carcinoma of the bladder with choriocarcinomatous differentiation A report of two cases and review of the literature. Urol Oncol. 1998;4:39–42.
pubmed: 21227189
doi: 10.1016/S1078-1439(98)00030-1
Damjanov I, Solter D. Yolk sac carcinoma grown from mouse egg cylinder. Arch Pathol. 1973;95:182–4.
pubmed: 4686509
Hovelson DH, Udager AM, McDaniel AS, Grivas P, Palmbos P, Tamura S, et al. Targeted DNA and RNA sequencing of paired urothelial and squamous bladder cancers reveals discordant genomic and transcriptomic events and unique therapeutic implications. Eur Urol. 2018;74:741–53.
pubmed: 30033047
doi: 10.1016/j.eururo.2018.06.047
Cicin I, Saip P, Guney N, Eralp Y, Ayan I, Kebudi R, et al. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. Eur J Obstet Gynecol Reprod Biol. 2009;146:210–4.
pubmed: 19419810
doi: 10.1016/j.ejogrb.2009.02.052
Conter CF, Xia C, Gershenson D, Hurteau J, Covens A, Pashankar F, et al. Ovarian yolk sac tumors; does age matter? Int J Gynecol Cancer. 2018;28:77–84.
doi: 10.1097/IGC.0000000000001149